{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:55:18Z","timestamp":1769316918407,"version":"3.49.0"},"reference-count":51,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2023,1,1]]},"DOI":"10.1248\/bpb.b22-00617","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T22:12:49Z","timestamp":1672524769000},"page":"86-94","source":"Crossref","is-referenced-by-count":2,"title":["Altered Pharmacological Efficacy of Phenobarbital with the Treatment of 7,8-Dihydroxyflavone, an Agonist of Tropomyosin Receptor Kinase B, in Rats"],"prefix":"10.1248","volume":"46","author":[{"given":"Keiichiro","family":"Suzuki","sequence":"first","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Aiba","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Matzke GR, Comstock TJ. Chapter 9: influence of renal function and dialysis on drug disposition. Applied Pharmacokinetics and Pharmacodynamics. Principles of Therapeutic Drug Monitoring<\/i>. (Burton ME, Shaw LM, Schentag JJ, Evans WE eds.) Lippincott Williams & Wilkins, Baltimore, pp. 187\u2013212 (2006)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Dhondt A, Vanholder R, Van Biesen W, Lameire N. The removal of uremic toxins. Kidney Int. Suppl.<\/i>, 76<\/b>, S47\u2013S59 (2000).","DOI":"10.1046\/j.1523-1755.2000.07606.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A. Normal and pathologic concentrations of uremic toxins. J. Am. Soc. Nephrol.<\/i>, 23<\/b>, 1258\u20131270 (2012).","DOI":"10.1681\/ASN.2011121175"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Keller F, Maiga M, Neumayer HH, Lode H, Distler A. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease. Eur. J. Drug Metab. Pharmacokinet.<\/i>, 9<\/b>, 275\u2013282 (1984).","DOI":"10.1007\/BF03189651"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sakai T, Yamasaki K, Sako T, Kragh-Hansen U, Suenaga A, Otagiri M. Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharm. Res.<\/i>, 18<\/b>, 520\u2013524 (2001).","DOI":"10.1023\/A:1011014629551"},{"key":"6","unstructured":"6) MacKichan JJ. Chapter 6: influence of protein binding and use of unbound (free) drug concentrations. Applied Pharmacokinetics and Pharmacodynamics. Principles of Therapeutic Drug Monitoring<\/i>. (Burton ME, Shaw LM, Schentag JJ, Evans WE eds.) Lippincott Williams & Wilkins, Baltimore, pp. 82\u2013120 (2006)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kusaba J, Kajikawa N, Kawasaki H, Kurosaki Y, Aiba T. Comparative study on altered hepatic metabolism of CYP3A substrates in rats with glycerol-induced acute renal failure. Biopharm. Drug Dispos.<\/i>, 33<\/b>, 22\u201329 (2012).","DOI":"10.1002\/bdd.1774"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kajikawa N, Doi M, Kusaba J, Aiba T. Effect of carrageenan-induced acute peripheral inflammation on the pharmacokinetics and hepatic metabolism of midazolam in rats. Drug Metab. Pharmacokinet.<\/i>, 29<\/b>, 400\u2013406 (2014).","DOI":"10.2133\/dmpk.DMPK-14-RG-020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kojina M, Suzuki K, Nishiwaki A, Aiba T. Acute peripheral inflammation increases plasma concentration of hypoglycemic agent nateglinide with decreased hepatic drug-metabolizing activity in rats. Biol. Pharm. Bull.<\/i>, 44<\/b>, 96\u2013102 (2021).","DOI":"10.1248\/bpb.b20-00677"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Iber H, Chen Q, Cheng PY, Morgan ET. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NF-\u03baB binding at the transcription start site. Arch. Biochem. Biophys.<\/i>, 377<\/b>, 187\u2013194 (2000).","DOI":"10.1006\/abbi.2000.1772"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Riddick DS, Lee C, Bhathena A, Timsit YE, Cheng PY, Morgan ET, Prough RA, Ripp SL, Miller KK, Jahan A, Chiang JY. Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab. Dispos.<\/i>, 32<\/b>, 367\u2013375 (2004).","DOI":"10.1124\/dmd.32.4.367"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y. Role of NF-\u03baB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450\u20023A4 by proinflammatory agents. J. Biol. Chem.<\/i>, 281<\/b>, 17882\u201317889 (2006).","DOI":"10.1074\/jbc.M601302200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct. Target. Ther.<\/i>, 2<\/b>, 17023 (2017).","DOI":"10.1038\/sigtrans.2017.23"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wu KC, Lin CJ. The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: evidences in inflammatory diseases and age-related disorders. J. Food Drug Anal.<\/i>, 27<\/b>, 48\u201359 (2019).","DOI":"10.1016\/j.jfda.2018.11.005"},{"key":"15","unstructured":"15) Danhof M, Hisaoka M, Levy G. Kinetics of drug action in disease states. II. Effect of experimental renal dysfunction on phenobarbital concentrations in rats at onset of loss of righting reflect. J. Pharmacol. Exp. Ther.<\/i>, 230<\/b>, 627\u2013631 (1984)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Okada A, Suzuki K, Hara K, Kojina M, Aiba T. In vivo<\/i> study on mechanism underlying increased pharmacological effects of phenobarbital in rats with glycerol-induced acute renal failure. Biol. Pharm. Bull.<\/i>, 42<\/b>, 501\u2013506 (2019).","DOI":"10.1248\/bpb.b18-00659"},{"key":"17","unstructured":"17) Koester J, Siegelbaum SA. Chapter 6: Membrane Potential and the Passive Electrical Properties of the Neuron. Principles of Neural Science 5\/e.<\/i> (Kandel ER, Schwartz JH, Jessel TM, Siegelbaum SA, Hudspeth AJ eds.) McGraw-Hill, New York, pp. 126\u2013148 (2012)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Murgu\u00eda-Castillo J, Beas-Z\u00e1rate C, Rivera-Cervantes MC, Feria-Velasco AI, Ure\u00f1a-Guerrero ME. NKCC1 and KCC2 protein expression is sexually dimorphic in the hippocampus and entorhinal cortex of neonatal rats. Neurosci. Lett.<\/i>, 552<\/b>, 52\u201357 (2013).","DOI":"10.1016\/j.neulet.2013.07.038"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Aytan N, Choi JK, Carreras I, Crabtree L, Nguyen B, Lehar M, Blusztajn JK, Jenkins BG, Dedeoglu A. Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer\u2019s disease. Eur. J. Pharmacol.<\/i>, 828<\/b>, 9\u201317 (2018).","DOI":"10.1016\/j.ejphar.2018.02.045"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) He J, Xiang Z, Zhu X, Ai Z, Shen J, Huang T, Liu L, Ji W, Li T. Neuroprotective effects of 7,8-dihydroxyflavone on midbrain dopaminergic neurons in MPP+<\/sup>-treated monkeys. Sci. Rep.<\/i>, 6<\/b>, 34339 (2016).","DOI":"10.1038\/srep34339"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Chang H-A, Wang Y-H, Tung C-S, Yeh C-B, Liu Y-P. 7,8-Dihydroxyflavone, a tropomyosin-kinase related receptor B agonist, produces fast-onset antidepressant-like effects in rats exposed to chronic mild stress. Psychiatry Investig.<\/i>, 13<\/b>, 531\u2013540 (2016).","DOI":"10.4306\/pi.2016.13.5.531"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Jang S-W, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 107<\/b>, 2687\u20132692 (2010).","DOI":"10.1073\/pnas.0913572107"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Liu C, Chan CB, Ye K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl. Neurodegener.<\/i>, 5<\/b>, 2 (2016).","DOI":"10.1186\/s40035-015-0048-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Minichiello L, Calella AM, Medina DL, Bonhoeffer T, Klein R, Korte M. Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron<\/i>, 36<\/b>, 121\u2013137 (2002).","DOI":"10.1016\/S0896-6273(02)00942-X"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Rivera C, Voipio J, Thomas-Crusells J, Li H, Emri Z, Sipil\u00e4 S, Payne JA, Minichiello L, Saarma M, Kaila K. Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2. J. Neurosci.<\/i>, 24<\/b>, 4683\u20134691 (2004).","DOI":"10.1523\/JNEUROSCI.5265-03.2004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Minichiello L. TrkB signalling pathways in LTP and learning. Nat. Rev. Neurosci.<\/i>, 10<\/b>, 850\u2013860 (2009).","DOI":"10.1038\/nrn2738"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Agrawal R, Noble E, Tyagi E, Zhuang Y, Ying Z, Gomez-Pinilla F. Flavonoid derivative 7,8-DHF attenuates TBI pathology via<\/i> TrkB activation. Biochim. Biophys. Acta<\/i>, 1852<\/b>, 862\u2013872 (2015).","DOI":"10.1016\/j.bbadis.2015.01.018"},{"key":"28","unstructured":"28) Paxinos G, Watson C. The rat brain in stereotaxic coordinates 6\/e.<\/i> Academic Press, New York (2009)."},{"key":"29","unstructured":"29) Mihic SJ, Harris RA. Chapter 17: hypnotics and sedatives. The Pharmacological Basis of Therapeutics 12\/e.<\/i> (Brunton LL, Chabner BA, Knollman BC eds.) McGraw-Hill, New York, pp. 457\u2013480 (2011)."},{"key":"30","unstructured":"30) Patel MP, Patel HH, Roth DM. Chapter 19: general anesthetics and therapeutic gases. The Pharmacological Basis of Therapeutics 12\/e.<\/i> (Brunton LL, Chabner BA, Knollman BC eds.) McGraw-Hill, New York, pp. 527\u2013564 (2011)."},{"key":"31","unstructured":"31) Chung SJ, Ramanathan VK, Brett CM, Giacomini KM. Saturable disposition of taurine in the rat cerebrospinal fluid. J. Pharmacol. Exp. Ther.<\/i>, 276<\/b>, 676\u2013682 (1996)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ye Z-Y, Li D-P, Byun HS, Li L, Pan H-L. NKCC1 upregulation disrupts chloride homeostasis in the hypothalamus and increases neuronal activity-sympathetic drive in hypertension. J. Neurosci.<\/i>, 32<\/b>, 8560\u20138568 (2012).","DOI":"10.1523\/JNEUROSCI.1346-12.2012"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Zhang F, Wang Y, Wang T, Yao L, Lam SM, Huang X, Fan J, Wang Q, Liu L, Jiang Y, Zhang H, Shi L, Yu M, Shui G, Wang Y, Gao F, Zhang X, Xu Z. cTAGE5\/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 115<\/b>, E9449\u2013E9458 (2018).","DOI":"10.1073\/pnas.1804083115"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Yuan C, Dai C, Li Z, Zheng L, Zhao M, Dong S. Bexarotene improve depression-like behaviour in mice by protecting against neuro-inflammation and synaptic damage. Neurochem. Res.<\/i>, 45<\/b>, 1500\u20131509 (2020).","DOI":"10.1007\/s11064-020-03012-3"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Fang Y, Shi B, Liu X, Luo J, Rao Z, Liu R, Zeng N. Xiaoyao pills attenuate inflammation and nerve injury induced by lipopolysaccharide in hippocampal neurons in vitro.<\/i> Neural Plast.<\/i>, 2020<\/b>, 8841332 (2020).","DOI":"10.1155\/2020\/8841332"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Doi M, Kajikawa N, Aiba T. Effects of dexamethasone to reverse decreased hepatic midazolam metabolism in rats with acute renal failure. Xenobiotica<\/i>, 50<\/b>, 506\u2013514 (2020).","DOI":"10.1080\/00498254.2019.1655680"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Kim C-H, Xiong WC, Mei L. Inhibition of MuSK expression by CREB interacting with a CRE-like element and MyoD. Mol. Cell. Biol.<\/i>, 25<\/b>, 5329\u20135338 (2005).","DOI":"10.1128\/MCB.25.13.5329-5338.2005"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Rantam\u00e4ki T. TrkB neurotrophin receptor at the core of antidepressant effects, but how? Cell Tissue Res.<\/i>, 377<\/b>, 115\u2013124 (2019).","DOI":"10.1007\/s00441-018-02985-6"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Sommerfeld MT, Schweigreiter R, Barde YA, Hoppe E. Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. J. Biol. Chem.<\/i>, 275<\/b>, 8982\u20138990 (2000).","DOI":"10.1074\/jbc.275.12.8982"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Haapasalo A, Sipola I, Larsson K, Akerman KEO, Stoilov P, Stamm S, Wong G, Castren E. Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms. J. Biol. Chem.<\/i>, 277<\/b>, 43160\u201343167 (2002).","DOI":"10.1074\/jbc.M205202200"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Hartmann M, Brigadski T, Erdmann KS, Holtmann B, Sendtner M, Narz F, Le\u00dfmann V. Truncated TrkB receptor-induced outgrowth of dendritic filopodia involves the p75 neurotrophin receptor. J. Cell Sci.<\/i>, 117<\/b>, 5803\u20135814 (2004).","DOI":"10.1242\/jcs.01511"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Barbato C, Ruberti F, Pieri M, Vilardo E, Costanzo M, Ciotti MT, Zona C, Cogoni C. MicroRNA-92 modulates K(+) Cl(\u2212) co-transporter KCC2 expression in cerebellar granule neurons. J. Neurochem.<\/i>, 113<\/b>, 591\u2013600 (2010).","DOI":"10.1111\/j.1471-4159.2009.06560.x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Lippi G, Fernandes CC, Ewell LA, John D, Romoli B, Curia G, Taylor SR, Frady EP, Jensen AB, Liu JC, Chaabane MM, Belal C, Nathanson JL, Zoli M, Leutgeb JK, Biagini G, Yeo GW, Berg DK. MicroRNA-101 regulates multiple developmental programs to constrain excitation in adult neural networks. Neuron<\/i>, 92<\/b>, 1337\u20131351 (2016).","DOI":"10.1016\/j.neuron.2016.11.017"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Obrietan K, Gao XB, van den Pol AN. Excitatory actions of GABA increase BDNF expression via<\/i> a MAPK-CREB\u2013dependent mechanism\u2014a positive feedback circuit in developing neurons. J. Neurophysiol.<\/i>, 88<\/b>, 1005\u20131015 (2002).","DOI":"10.1152\/jn.2002.88.2.1005"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Inoue M, Uriu T, Otani H, Hara M, Omori K, Inagaki C. Intracerebroventricular injection of ethacrynic acid induces status epilepticus. Eur. J. Pharmacol.<\/i>, 166<\/b>, 101\u2013106 (1989).","DOI":"10.1016\/0014-2999(89)90688-2"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Rivera C, Li H, Thomas-Crusells J, Lahtinen H, Viitanen T, Nanobashvili A, Kokaia Z, Airaksinen MS, Voipio J, Kaila K, Saarma M. BDNF-induced TrkB activation down-regulates the K+<\/sup>-Cl\u2212<\/sup> cotransporter KCC2 and impairs neuronal Cl\u2212<\/sup> extrusion. J. Cell Biol.<\/i>, 159<\/b>, 747\u2013752 (2002).","DOI":"10.1083\/jcb.200209011"},{"key":"47","unstructured":"47) Siegelbaum SA, Kandel ER, Yuste R. Chapter 10: synaptic integration in the central nervous system. Principles of Neural Science 5\/e.<\/i> (Kandel ER, Schwartz JH, Jessel TM, Siegelbaum SA, Hudspeth AJ eds.) McGraw-Hill, New York, pp. 210\u2013235 (2012)."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Greenfield LJ Jr. Molecular mechanisms of antiseizure drug activity at GABAA<\/sub> receptors. Seizure<\/i>, 22<\/b>, 589\u2013600 (2013).","DOI":"10.1016\/j.seizure.2013.04.015"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Farmer GE, Balapattabi K, Bachelor ME, Little JT, Cunningham JT. AT1a<\/sub> influences GABAA<\/sub>-mediated inhibition through regulation of KCC2 expression. Am. J. Physiol. Regul. Integr. Comp. Physiol.<\/i>, 315<\/b>, R972\u2013R982 (2018).","DOI":"10.1152\/ajpregu.00105.2018"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Laube M, Bossmann M, Thome UH. Glucocorticoids distinctively modulate the CFTR channel with possible implications in lung development and transition into extrauterine life. PLOS ONE<\/i>, 10<\/b>, e0124833 (2015).","DOI":"10.1371\/journal.pone.0124833"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Nejsum LN, Praetorius J, Nielsen S. NKCC1 and NHE1 are abundantly expressed in the basolateral plasma membrane of secretory coil cells in rat, mouse, and human sweat glands. Am. J. Physiol. Cell Physiol.<\/i>, 289<\/b>, C333\u2013C340 (2005).","DOI":"10.1152\/ajpcell.00228.2004"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/1\/46_b22-00617\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T03:21:59Z","timestamp":1673061719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/46\/1\/46_b22-00617\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b22-00617","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"b22-00617"}}